Pages that link to "Q69559055"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics of methotrexate (Q69559055):
Displaying 50 items.
- Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy (Q33411737) (← links)
- Intestinal and liver toxicity of antineoplastic drugs (Q33605823) (← links)
- Anti-folate resistance in leukemia: treatment with “high-dose” methotrexate and citrovorum factor (Q34066243) (← links)
- Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references (Q34081090) (← links)
- Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis (Q34222693) (← links)
- Clinical pharmacokinetics of commonly used anticancer drugs. (Q34707699) (← links)
- Bilateral septic knee arthritis after treatment of an ectopic pregnancy with methotrexate (Q34982209) (← links)
- Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate (Q36431395) (← links)
- Antineoplastic drugs in 1990. A review (Part II). (Q37932369) (← links)
- Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy (Q38537378) (← links)
- Antineoplastic drugs: clinical pharmacology and therapeutic use. (Q39496661) (← links)
- Pharmacologic considerations in the treatment of acute lymphoblastic leukemia (Q39522996) (← links)
- Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis (Q39540992) (← links)
- New developments on the mechanisms of action of antineoplastic drugs (Q39565319) (← links)
- A clinical pharmacologist's view of drug hepatotoxicity (Q39623440) (← links)
- Pharmacokinetics.Selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs (Q39635078) (← links)
- Methotrexate: clinical pharmacology, current status and therapeutic guidelines (Q39660818) (← links)
- The clinical pharmacology of methotrexate.new applications of an old drug (Q39716312) (← links)
- Clinical Pharmacokinetics of Methotrexate1 (Q39720628) (← links)
- Pharmacokinetics of anticancer drugs in children (Q39768346) (← links)
- High-dose Methotrexate Therapy-An Area of Uncertainty* (Q39852771) (← links)
- Pharmaceutical Sciences — 1973: Literature Review of Pharmaceutics (Q39944962) (← links)
- Methotrexate plasma decay kinetics: possible alteration in patients undergoing gut sterilization (Q40031175) (← links)
- Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs (Q40104510) (← links)
- The clinical pharmacology of methotrexate (Q40149030) (← links)
- Reappraisal of the use of methotrexate in rheumatic disease (Q40162216) (← links)
- Dose-Dependent Metabolism, Therapeutic Effect, and Toxicity of Anticancer Drugs in Man (Q40177601) (← links)
- Clinical pharmacokinetics of methotrexate in children (Q40184290) (← links)
- The determination of methotrexate in serum and urine (Q40311740) (← links)
- Dose-dependent pharmacokinetics and cancer chemotherapy (Q40313416) (← links)
- Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia (Q40624289) (← links)
- High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl) (Q40715884) (← links)
- Methotrexate and other chemotherapeutic agents used to treat psoriasis. (Q41095005) (← links)
- Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia (Q41494448) (← links)
- Methotrexate Concentrations in Biological Fluids: Comparison of Results Obtained by Radioimmunoassay and Direct Ligand Binding Radioassay (Q41529138) (← links)
- Serum profiles and safety of intermediate-dose (500-1,000 mg) methotrexate following IV and IM administration (Q41588896) (← links)
- Development and application of a radioimmunoassay for methotrexate (Q42578636) (← links)
- Renal function and the rate of disappearance of methotrexate from serum (Q43492583) (← links)
- Enhancement of methotrexate absorption by subdivision of dose (Q44147246) (← links)
- Prolongation and enhancement of serum methotrexate concentrations by probenecid (Q49901693) (← links)
- Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter (Q50720920) (← links)
- Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits. (Q52680287) (← links)
- Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses. (Q52682983) (← links)
- Mathematical modeling ?Guide to high-dose methotrexate infusion therapy (Q52778977) (← links)
- Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin. (Q53043144) (← links)
- Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method (Q53724864) (← links)
- Correlation of plasma methotrexate concentration with human chorionic gonadotropin and therapeutic response to low-dose methotrexate-citrovorum factor in low-medium-risk gestational trophoblastic tumors (Q54298024) (← links)
- Determination of methotrexate in plasma by on-column concentration and ion-exchange chromatography (Q66848124) (← links)
- Bioavailability of methotrexate: implications for clinical use (Q66992156) (← links)
- Identification of methotrexate and folic acid analogs by mass spectrometry (Q67287155) (← links)